Vesicular nanocarrier based treatment of skin fungal infections: Potential and emerging trends in nanoscale pharmacotherapy

[1]  A. Elaissari,et al.  Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications. , 2018, International journal of pharmaceutics.

[2]  Waleed Faisal,et al.  Enhanced skin deposition and delivery of voriconazole using ethosomal preparations , 2018, Journal of liposome research.

[3]  T. Webster,et al.  Elastic liposomes as novel carriers: recent advances in drug delivery , 2017, International journal of nanomedicine.

[4]  G. M. Soliman.  Nanoparticles as safe and effective delivery systems of antifungal agents: Achievements and challenges. , 2017, International journal of pharmaceutics.

[5]  D. Farghaly,et al.  Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation , 2017, AAPS PharmSciTech.

[6]  H. Benson.  Elastic Liposomes for Topical and Transdermal Drug Delivery. , 2009, Methods in molecular biology.

[7]  G. Abdelbary,et al.  Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation , 2017, AAPS PharmSciTech.

[8]  M. Carvalheiro,et al.  Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management. , 2017, Current pharmaceutical design.

[9]  S. Brijesh,et al.  Opportunities and Challenges for Niosomes as Drug Delivery Systems. , 2016, Current drug delivery.

[10]  M. Chorilli,et al.  Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy? , 2016, International journal of nanomedicine.

[11]  K. Pathak,et al.  Ethosomes as Vesicles for Effective Transdermal Delivery: From Bench to Clinical Implementation. , 2016, Current clinical pharmacology.

[12]  H. Maibach,et al.  Nano-Sized Technologies for Miconazole Skin Delivery. , 2016, Current pharmaceutical biotechnology.

[13]  M. Morilla,et al.  Topical amphotericin B in ultradeformable liposomes: Formulation, skin penetration study, antifungal and antileishmanial activity in vitro. , 2016, Colloids and surfaces. B, Biointerfaces.

[14]  Jeong-Yoon Kim.  Human fungal pathogens: Why should we learn? , 2016, Journal of Microbiology.

[15]  L. Kircik.  Advancements in Topical Antifungal Vehicles. , 2016, Journal of drugs in dermatology : JDD.

[16]  Amit Jain,et al.  Ethanol Based Vesicular Carriers in Transdermal Drug Delivery: Nanoethosomes and Transethosomes in Focus , 2016 .

[17]  G. De Rosa,et al.  Nanocarriers to Enhance the Accumulation of Vitamin K1 into the Skin , 2015, Pharmaceutical Research.

[18]  H. Maibach,et al.  Novel drug delivery strategies for improving econazole antifungal action. , 2015, International journal of pharmaceutics.

[19]  C. Müller-Goymann,et al.  Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[20]  O. Sammour,et al.  Recent advances in topical formulation carriers of antifungal agents. , 2015, Indian journal of dermatology, venereology and leprology.

[21]  M. Al-agamy,et al.  In vitro skin penetration and antimycotic activity of itraconazole loaded niosomes: Various non-ionic surfactants , 2015 .

[22]  K. Pathak,et al.  Topical delivery of drugs for the effective treatment of fungal infections of skin. , 2015, Current pharmaceutical design.

[23]  B. Conway,et al.  Lipid nanoparticles for dermal drug delivery. , 2015, Current pharmaceutical design.

[24]  D. Mcclements.  Encapsulation, protection, and release of hydrophilic active components: potential and limitations of colloidal delivery systems. , 2015, Advances in colloid and interface science.

[25]  A. Molinari,et al.  Liposomes as nanomedical devices , 2015, International journal of nanomedicine.

[26]  G. Elgart.  Subcutaneous (deep) fungal infections. , 2014, Seminars in cutaneous medicine and surgery.

[27]  N. K. Jain,et al.  Miconazole nitrate bearing ultraflexible liposomes for the treatment of fungal infection , 2014, Journal of liposome research.

[28]  B. Sudhakar,et al.  Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery. , 2014, Current drug delivery.

[29]  Aimee C. Smidt,et al.  Superficial fungal infections in children. , 2014, Pediatric clinics of North America.

[30]  Mohit Vij,et al.  Oleic acid vesicles: a new approach for topical delivery of antifungal agent , 2014, Artificial cells, nanomedicine, and biotechnology.

[31]  F. Rinaldi,et al.  Niosomes from 80s to present: the state of the art. , 2014, Advances in colloid and interface science.

[32]  P. Nenoff,et al.  Mycology – an update. Part 1: Dermatomycoses: Causative agents, epidemiology and pathogenesis , 2014, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[33]  R. Alany,et al.  Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations , 2014, Drug delivery.

[34]  N. Akhtar.  Vesicles: a recently developed novel carrier for enhanced topical drug delivery. , 2014, Current drug delivery.

[35]  L. Kumar,et al.  Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review , 2014, Artificial cells, nanomedicine, and biotechnology.

[36]  A. Attama,et al.  Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus , 2014, Expert opinion on drug delivery.

[37]  L. Kumar,et al.  Polymeric microparticles-based formulation for the eradication of cutaneous candidiasis: development and characterization , 2013, Pharmaceutical development and technology.

[38]  M. Morilla,et al.  Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations , 2013, International journal of nanomedicine.

[39]  B. Michniak-Kohn,et al.  Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. , 2013, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[40]  K. Pathak,et al.  Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of Econazole nitrate through epidermis , 2013, Pharmaceutical development and technology.

[41]  H. Hamishehkar,et al.  Niosomes as a propitious carrier for topical drug delivery , 2013, Expert opinion on drug delivery.

[42]  S. Güngör,et al.  New Formulation Strategies in Topical Antifungal Therapy , 2013 .

[43]  M. Ravi,et al.  Formulation and Evaluation of Econazole Niosomes , 2013 .

[44]  Vijay D. Wagh,et al.  Itraconazole Niosomes Drug Delivery System and Its Antimycotic Activity against Candida albicans , 2012, ISRN pharmaceutics.

[45]  N. Aggarwal,et al.  Preparation and evaluation of antifungal efficacy of griseofulvin loaded deformable membrane vesicles in optimized guinea pig model of Microsporum canis--dermatophytosis. , 2012, International journal of pharmaceutics.

[46]  D. Nagendrakumar,et al.  Formulation and evaluation of Ketoconazole niosomal gel drug delivery system , 2012, International journal of pharmaceutical investigation.

[47]  R. Arenas,et al.  Classification of subcutaneous and systemic mycoses. , 2012, Clinics in dermatology.

[48]  O. Abdallah,et al.  Propylene Glycol Liposomes as a Topical Delivery System for Miconazole Nitrate: Comparison with Conventional Liposomes , 2012, AAPS PharmSciTech.

[49]  K. Pathak,et al.  Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[50]  R. Tekade,et al.  Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment. , 2012, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[51]  S. Chong,et al.  A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. , 2012, Colloids and surfaces. B, Biointerfaces.

[52]  K. Pathak,et al.  Cavamax W7 Composite Ethosomal Gel of Clotrimazole for Improved Topical Delivery: Development and Comparison with Ethosomal Gel , 2012, AAPS PharmSciTech.

[53]  Madhu Gupta,et al.  Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis. , 2011, Chemistry and physics of lipids.

[54]  T. Einarson,et al.  An Overview of Topical Antifungal Therapy in Dermatomycoses , 1998, Drugs.

[55]  S. Meehan,et al.  Subcutaneous dematiaceous fungal infection. , 2011, Dermatology online journal.

[56]  I. Kaur,et al.  Spanlastics--a novel nanovesicular carrier system for ocular delivery. , 2011, International journal of pharmaceutics.

[57]  H. Kählig,et al.  Decrease of liposomal size and retarding effect on fluconazole skin permeation by lysine derivatives. , 2011, Journal of pharmaceutical sciences.

[58]  D. Mishra,et al.  Niosomes: a controlled and novel drug delivery system. , 2011, Biological & pharmaceutical bulletin.

[59]  Wolfgang Becker,et al.  Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.

[60]  S. Desaia,et al.  DEVELOPMENT AND EVALUATION OF ANTIFUNGAL TOPICAL NIOSOMAL GEL FORMULATION , 2011 .

[61]  I. Kaur,et al.  Topical delivery of antifungal agents , 2010, Expert opinion on drug delivery.

[62]  F. Severcan,et al.  Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics. , 2010, Bioscience reports.

[63]  A. Goyal,et al.  Development and characterization of oleic acid vesicles for the topical delivery of fluconazole , 2010, Drug delivery.

[64]  N. Yuksel,et al.  Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. , 2010, Journal of pharmaceutical sciences.

[65]  S. Talegaonkar,et al.  Niosomes in sustained and targeted drug delivery: some recent advances , 2009, Journal of drug targeting.

[66]  Rakesh Patel,et al.  Formulation and Evaluation of Carbopol Gel Containing Liposomes of Ketoconazole. (Part-II) , 2009 .

[67]  A. Misra,et al.  Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. , 2009, Indian journal of experimental biology.

[68]  A. Madgulkar,et al.  Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery , 2009, AAPS PharmSciTech.

[69]  Shinichi Watanabe.  [Dermatomycosis--classification, etiology, pathogenesis, and treatment]. , 2008, Nihon rinsho. Japanese journal of clinical medicine.

[70]  D. Lachenmeier.  Journal of Occupational Medicine and Toxicology Safety Evaluation of Topical Applications of Ethanol on the Skin and inside the Oral Cavity , 2008 .

[71]  P. Giunchedi,et al.  Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in‐vitro characterization, ex‐vivo and in‐vivo studies , 2007, The Journal of pharmacy and pharmacology.

[72]  S. Guterres,et al.  Polymeric Nanoparticles, Nanospheres and Nanocapsules, for Cutaneous Applications , 2007, Drug target insights.

[73]  Y. Kalia,et al.  New developments in topical antifungal therapy , 2006 .

[74]  H. Benson.  Transfersomes for transdermal drug delivery , 2006, Expert opinion on drug delivery.

[75]  S. Esmat,et al.  Efficacy of topical griseofulvin in treatment of tinea corporis , 2006, Mycoses.

[76]  Aditya K. Gupta,et al.  Dermatophytosis: the management of fungal infections. , 2005, Skinmed.

[77]  H. Maibach,et al.  Liposomes and Niosomes as Topical Drug Delivery Systems , 2005, Skin Pharmacology and Physiology.

[78]  M. Dahl,et al.  Topical Therapy for Fungal Infections , 2004, American journal of clinical dermatology.

[79]  Biana Godin,et al.  Ethosomes: new prospects in transdermal delivery. , 2003, Critical reviews in therapeutic drug carrier systems.

[80]  C. R. Daniel,et al.  Treatments of tinea pedis. , 2003, Dermatologic clinics.

[81]  B. L. Hainer.  Dermatophyte infections. , 2003, American family physician.

[82]  R. Agarwal.  Preparation and In Vitro Evaluation of Miconazole Nitrate-Loaded Topical Liposomes , 2002 .

[83]  A. Goldstein,et al.  Mycotic infections. Effective management of conditions involving the skin, hair, and nails. , 2000, Geriatrics.

[84]  P. Pohl,et al.  Changes of intrinsic membrane potentials induced by flip-flop of long-chain fatty acids. , 2000, Biochemistry.

[85]  B. Amichai,et al.  Adverse drug reactions of the new oral antifungal agents – terbinafine, fluconazole, and itraconazole , 1998, International journal of dermatology.

[86]  A. Blume,et al.  Interaction of phospholipid liposomes with lipid model mixtures for stratum corneum lipids , 1993 .

[87]  G. Cevc,et al.  Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. , 1992, Biochimica et biophysica acta.

[88]  N. Penneys,et al.  Complex viral and fungal skin lesions of patients with acquired immunodeficiency syndrome. , 1987, Journal of the American Academy of Dermatology.

[89]  Z. Tökés,et al.  Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[90]  R. Handjani-Vila,et al.  Dispersions of lamellar phases of non‐ionic lipids in cosmetic products , 1979, International journal of cosmetic science.

[91]  M. Hicks,et al.  Ufasomes are Stable Particles surrounded by Unsaturated Fatty Acid Membranes , 1973, Nature.